SCHEMBL6049592

SCHEMBL6049592

CCCCc1ccon1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL6014423 0.98 CYP1A2 (0.42)
SCHEMBL1221781 0.94 KCNH2 (0.48)
SCHEMBL28018296 0.92 KCNH2 (0.52)
SCHEMBL20209685 0.92 KCNH2 (0.52)
SCHEMBL21645767 0.92 KCNH2 (0.52)
SCHEMBL21186452 0.92 KCNH2 (0.52)
Alcohol SCHEMBL22495162 0.88 KCNH2 (0.44)
SCHEMBL3834698 0.86
Piperazine SCHEMBL1442999 0.84 KCNH2 (0.41)
SCHEMBL22266283 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102639539-B process for the preparation of imidazo [2,1-b ] [1,3] benzothiazole derivatives AMBIT BIOSCIENCES CORP 2014-12-10 CN claimed
US-11643408-B2 N-pyridinyl acetamide derivatives as inhibitors of the WNT signaling pathway REDX PHARMA PLC (GB) 2023-05-09 US disclosed
WO-2023075479-A1 NOVEL THIENO[2,3-D]PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER OR AUTOIMMUNE DISEASE COMPRISING SAME AS ACTIVE INGREDIENT 재단법인 대구경북첨단의료산업진흥재단 2023-05-04 WO disclosed
US-9284332-B2 Process for the preparation of imidazo[2,1-B][1,3]benzothiazole derivatives AMBIT BIOSCIENCES CORPORATION (US) 2016-03-15 US disclosed
CN-105254557-A ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RAQUALIA PHARMA INC 2016-01-20 CN disclosed
CN-105188383-A Herbicidal compounds SYNGENTA PARTICIPATIONS AG 2015-12-23 CN disclosed
CN-105130957-A ARYL SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS RAQUALIA PHARMA INC 2015-12-09 CN disclosed
CN-102884063-B Can be used as the azabicyclo imdazole derivatives of the replacement of TRPM8 receptor modulators JANSSEN PHARMACEUTICA N.V. (BE) 2015-11-25 CN disclosed
CN-104995173-A Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO LTD 2015-10-21 CN disclosed
CN-102282147-B Bicyclic pyrazolo-heterocycles CARA THERAPEUTICS, INC. (US) 2015-09-30 CN disclosed
CN-101501023-A Phenyl-substituted heteroaryl derivatives and their use as antitumor agents BOEHRINGER INGELHEIM INT (DE) 2009-08-05 CN disclosed
CN-100999533-A Bridged binuclear metal hydrazone complex and its synthesis method SHANGHAI INST OPTICS & FINE ME (CN) 2007-07-18 CN disclosed
EP-1041982-A4 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER PHARMACEUTICALS CORP (US) 2006-06-14 EP disclosed
CN-1562985-A Preparation method of 5-substituted-3-aminoisoxazole compound SHANGHAI INST OPTICS & FINE ME (CN) 2005-01-12 CN disclosed
CN-1456555-A Isoxazole-azo-cyclohexanedione metal chelate and preparation method thereof SHANGHAI OPTICAL PRECISION (CN) 2003-11-19 CN disclosed
CN-1438221-A isoxazole-azo-diketone metal azo chelate and preparation method thereof SHANGHAI OPTICAL PREC MECHANIC (CN) 2003-08-27 CN disclosed
CN-1093859-C Novel indole-2,3-done-3-oxime derivatives NEUROSEARCH AS (DK) 2002-11-06 CN disclosed
EP-1041982-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS Bayer Corporation (US) 2000-10-11 EP disclosed
WO-1999032111-A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS BAYER CORPORATION (US) 1999-07-01 WO disclosed
CN-1207100-A Novel indole-2,3-done-3-oxime derivatives NEUROSEARCH AS (DK) 1999-02-03 CN disclosed